Compliance Insight Podcasts: Implementing Process Validation - Episode 3
Step-by-Step Validation for Bio/Pharmaceuticals: Meeting New Regulatory Expectations
Optimizing cleaning validation - Episode 3
Listeners will walk away with knowledge of how to prevent cross-contamination in bio/pharmaceutical manufacturing using a risk-based approach, including how to handle unique challenges that occur with continuous processing and revalidation. Best practices and regulatory expectations from ICH Q9 guideline, the ISPE Risk MaPP guideline, and the ASTM 2500 Standard Guide for Specification, Design, and Verification for Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment will be addressed.
Compliance Insight podcast Series>>
Add this Podcast feed to your media player
Sponsored By:
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
